A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

被引:217
|
作者
Heijnen, Esther M. E. W.
Eijkemans, Marinus J. C.
De Klerk, Cora
Polinder, Suzanne
Beckers, Nicole G. M.
Klinkert, Ellen R.
Broekmans, Frank J.
Passchier, Jan
Macklon, Nick S.
Fauser, Bart C. J. M.
机构
[1] Univ Med Ctr, Dept Reprod Med & Gynaecol, NL-3584 CX Utrecht, Netherlands
[2] Erasmus MC, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands
[3] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[4] Erasmus MC, Div Reprod Med, Rotterdam, Netherlands
来源
LANCET | 2007年 / 369卷 / 9563期
关键词
D O I
10.1016/S0140-6736(07)60360-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mild in-vitro fertilisation (IVF) treatment might lessen both patients' discomfort and multiple births, with their associated risks. We aimed to test the hypothesis that mild IVF treatment can achieve the same chance of a pregnancy resulting in term livebirth within 1 year compared with standard treatment, and can also reduce patients' discomfort, multiple pregnancies, and costs. Methods We did a randomised, non-inferiority effectiveness trial. 404 patients were randomly assigned to undergo either mild treatment (mild ovarian stimulation with gonadotropin-releasing hormone [GnRH] antagonist cotreatment combined with single embryo transfer) or a standard treatment (stimulation with a GnRH agonist long-protocol and transfer of two embryos). Primary endpoints were proportion of cumulative pregnancies leading to term livebirth within 1 year after randomisation (with a non-inferiority threshold of -12.5%), total costs per couple up to 6 weeks after expected date of delivery, and overall discomfort for patients. Analysis was by intention to treat. This trial is registered as an International Standard Randomised Clinical Trial, number ISRCTN35766970. Findings The proportions of cumulative pregnancies that resulted in term livebirth after 1 year were 43.4% with mild treatment and 44.7% with standard treatment (absolute number of patients=86 for both groups). The lower limit of the one-sided 95% CI was -9.8%. The proportion of couples with multiple pregnancy outcomes was 0.5% with mild IVF treatment versus 13.1% (p<0.0001) with standard treatment, and mean total costs were E8333 and E10745, respectively (difference E2412, 95% CI 703-4131). There were no significant differences between the groups in the anxiety depression, physical discomfort, or sleep quality of the mother. Interpretation Over 1 year of treatment, cumulative rates of term livebirths and patients' discomfort are much the same for mild ovarian stimulation with single embryos transferred and for standard stimulation with two embryos transferred. However, a mild IVF treatment protocol can substantially reduce multiple pregnancy rates and overall costs.
引用
收藏
页码:743 / 749
页数:7
相关论文
共 50 条
  • [1] A Mild Treatment Strategy for the In-vitro Fertilisation A randomized non-inferiority Trial
    Steck, T.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2007, 5 (03): : 174 - 175
  • [2] A mild treatment strategy for in-vitro fertilisation: A randomized non-inferiority trial [Sanfte behandlungsstrategie für die in-vitro-fertilisation: Randomisierte nicht-inferioritäts-studie]
    Steck T.
    [J]. Gynäkologische Endokrinologie, 2007, 5 (3) : 174 - 176
  • [3] OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trial
    Sheppard, James P.
    Burt, Jenni
    Lown, Mark
    Temple, Eleanor
    Benson, John
    Ford, Gary A.
    Heneghan, Carl
    Hobbs, F. D. Richard
    Jowett, Sue
    Little, Paul
    Mant, Jonathan
    Mollison, Jill
    Nickless, Alecia
    Ogburn, Emma
    Payne, Rupert
    Williams, Marney
    Yu, Ly-Mee
    McManus, Richard J.
    [J]. BMJ OPEN, 2018, 8 (09):
  • [4] Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial
    Ragni, Guido
    Levi-Setti, Paolo E.
    Fadini, Rubens
    Brigante, Claudio
    Scarduelli, Claudia
    Alagna, Federica
    Arfuso, Veronica
    Mignini-Renzini, Mario
    Candiani, Massimo
    Paffoni, Alessio
    Somigliana, Edgardo
    [J]. REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2012, 10
  • [5] Live birth after in vitro maturation versus standard in vitro fertilisation for women with polycystic ovary syndrome: protocol for a non-inferiority randomised clinical trial
    Zheng, Xiaoying
    Guo, Wei
    Zeng, Lin
    Zheng, Danni
    Yang, Shuo
    Wang, Lina
    Wang, Rui
    Mol, Ben W.
    Li, Rong
    Qiao, Jie
    [J]. BMJ OPEN, 2020, 10 (04):
  • [6] Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial
    Montini, Giovanni
    Toffolo, Antonella
    Zucchetta, Pietro
    Dall'Amico, Roberto
    Gobber, Daniela
    Calderan, Alessandro
    Maschio, Francesca
    Pavanello, Luigi
    Molinari, Pier Paolo
    Scorrano, Dante
    Zanchetta, Sergio
    Cassar, Walburga
    Brisotto, Paolo
    Corsini, Andrea
    Sartori, Stefano
    Da Dalt, Liviana
    Murer, Luisa
    Zacchello, Graziella
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7616): : 386 - 388A
  • [7] Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial
    Williams, Hywel C.
    Wojnarowska, Fenella
    Kirtschig, Gudula
    Mason, James
    Godec, Thomas R.
    Schmidt, Enno
    Chalmers, Joanne R.
    Childs, Margaret
    Walton, Shernaz
    Harman, Karen
    Chapman, Anna
    Whitham, Diane
    Nunn, Andrew J.
    [J]. LANCET, 2017, 389 (10079): : 1630 - 1638
  • [8] Is this a non-inferiority trial?
    O'Halloran, Peter
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (02) : 154 - 154
  • [9] The impact of an inappropriate non-inferiority margin in a non-inferiority trial
    Gupta, Reena
    Gupta, Himanshu
    Banker, Manish
    [J]. HUMAN REPRODUCTION, 2016, 31 (12) : 2892 - 2893
  • [10] Brief treatment for PTSD: A non-inferiority trial
    Sloan, Denise M.
    Marx, Brian P.
    Resick, Patricia A.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2016, 48 : 76 - 82